𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic effect of secretin in patients with jaundice; Double-blind placebo-controlled multicentric trial

✍ Scribed by Yohei Fukumoto; Kiwamu Okita; Takahiro Kodama; Shoshi Matsuda; Susumu Kawamura; Kazuo Harima; Yoshio Harada; Kenji Kawaguchi; Yohzo Iida; Tomomi Konishi; Keijiro Andoh; Hiroko Tanaka; Tetsuro Hanta; Tomoo Sekhani; Toshihiko Takenami; Takahiro Yamasaki; Satoyoshi Yamashita; Hiroshi Fujimura; Masakatsu Shimada; Michiko Kohzu; Kojiro Shigeta; Hiroyuki Shirasawa

Publisher
Springer Japan
Year
1996
Tongue
English
Weight
775 KB
Volume
31
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Doxazosin in combination with atenolol i
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
✍ M. Searle; R. Dathan; S. Dean; C. C. Christensen; A. Westheim πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 184 KB

Doxazosin (mean dose 11 mg) given once daily in combination with 100 mg atenolol (n = 44) was compared with placebo and atenolol (n = 43) in a double-blind, multicenter study in patients with mild to moderate essential hypertension. In the atenolol/doxazosin-treated group, standing blood pressure si

Gabapentin in patients with the pruritus
Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial
✍ Nora V. Bergasa; Monnie McGee; Iona H. Ginsburg; Danielle Engler πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 420 KB πŸ‘ 2 views

Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the

Double-blind placebo controlled clinical
Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency
✍ I. Bakran; B. Vrhovac; B. Ε tangl; Đ. Tabori; A. Ivičevic; V. Todič; F. Kandare πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 518 KB

The efficacy and safety of almitrine bismesylate, a new respiratory stimulant, in patients with the hypoxaemic form of chronic respiratory insufficiency caused by chronic bronchitis and emphysema has been assessed. The multicentre trial of 12 weeks duration was double-blind and placebo controlled, w